Identification of somatic copy number variations in plasma cell free DNA correlating with intrinsic resistances to EGFR targeted therapy in T790M negative non-small cell lung cancer

BACKGROUND: About 20–30% EGFR-mutant non-small lung cancer show intrinsic resistance to EGFR targeted therapies. Compared to T790M positive in acquired resistance patients, little is known about EGFR-TKI intrinsic resistance for T790M negative patients. METHODS: Thirty-one patients with advanced sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Lucheng, Liang, Jiafeng, Xia, Bing, Xu, Yasi, Qian, Ziliang, Ma, Shenglin, Zhang, Shirong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138977/
https://www.ncbi.nlm.nih.gov/pubmed/32274156
http://dx.doi.org/10.21037/jtd.2019.12.97

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138977/
https://www.ncbi.nlm.nih.gov/pubmed/32274156
http://dx.doi.org/10.21037/jtd.2019.12.97

Ejemplares similares